Literature DB >> 25962939

miR-433 inhibits oral squamous cell carcinoma (OSCC) cell growth and metastasis by targeting HDAC6.

Xiao-chun Wang1, Ying Ma1, Pei-song Meng1, Jia-long Han1, Hai-yan Yu1, Liang-jia Bi2.   

Abstract

OBJECTIVES: The aim of this study was to determine expression levels of miR-433 in oral squamous cell carcinomas (OSCCs) and adjacent normal tissues, and explore its biological functions in OSCCs.
METHODS: miR-433 level in oral squamous cell carcinomas (OSCCs) and adjacent normal tissues was tested by real-time qPCR. The effect of miR-433 on cell growth was detected by MTT and colony formation assays. The tumorigenicity of miR-433 transfected OSCCs was evaluated in nude mice model. Transwell and wound healing assays were performed to detect the effect of miR-433 on OSCCs cell invasion and migration. Luciferase reporter gene assays were performed to identify the interaction between miR-433 and 3'UTR of HDAC6 mRNA. The protein level of HDAC6, BCL2, CCNE1, MMP1 and MMP9 was determined by Western blotting. Immunohistochemistry analysis was performed to detect the expression of HDAC6 in oral squamous cell carcinomas (OSCCs) and adjacent normal tissues.
RESULTS: We found that miR-433 was frequently down-regulated in OSCCs compared with adjacent normal tissues. Restoring miR-433 expression in OSCC cells dramatically suppressed cells growth, invasion and migration. Importantly, our data showed that miR-433 downregulated the expression of HDAC6 through directly targeting its 3'UTR.
CONCLUSION: Our data suggest that miR-433 exerts its tumor suppressor function by targeting HDAC6, leading to the inhibition of OSCC cell growth, invasion and migration, which suggest that miR-433 may be potential target for diagnostic and therapeutic applications in OSCC.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  HDAC6; HSC2; Oral squamous cell carcinoma (OSCC); SAS; miR-433

Mesh:

Substances:

Year:  2015        PMID: 25962939     DOI: 10.1016/j.oraloncology.2015.04.010

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  25 in total

1.  [MiR-433 reverses chemoresistance to docetaxel by targeting Notch1 in breast cancer cells].

Authors:  Xiaolei Hu; Pingmei Huang; Jie Wang; Wan He; Pan Zhao; Guangyu Yao; Changsheng Ye
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-07-30

2.  miR-433 accelerates acquired chemoresistance of gallbladder cancer cells by targeting cyclin M.

Authors:  Jianhua Yu; Weiguang Zhang; Baochun Lu; Hongwei Qian; Haijun Tang; Zhiyang Zhu; Xinggui Yuan; Peitu Ren
Journal:  Oncol Lett       Date:  2017-12-28       Impact factor: 2.967

3.  HDAC6/FOXP3/HNF4α axis promotes bile acids induced gastric intestinal metaplasia.

Authors:  Luyao Zhang; Na Wang; Min Chen; Siran Wu; Jiaoxia Zeng; Fenli Zhou; Qiong Wu; Junye Liu; Yongquan Shi
Journal:  Am J Cancer Res       Date:  2022-03-15       Impact factor: 6.166

4.  MicroRNA-433 targets AKT3 and inhibits cell proliferation and viability in breast cancer.

Authors:  Xiaolei Hu; Jie Wang; Wan He; Pan Zhao; Changsheng Ye
Journal:  Oncol Lett       Date:  2018-01-16       Impact factor: 2.967

5.  The epigenetic silencing of microRNA-433 facilitates the malignant phenotypes of non-small cell lung cancer by targeting CREB1.

Authors:  Weige Wang; Chao Feng; Wenqiang Zhang; Yong Long; Xian'en Fa
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

6.  Changes in the miRNA-mRNA Regulatory Network Precede Motor Symptoms in a Mouse Model of Multiple System Atrophy: Clinical Implications.

Authors:  Simon Schafferer; Rimpi Khurana; Violetta Refolo; Serena Venezia; Edith Sturm; Paolo Piatti; Clara Hechenberger; Hubert Hackl; Roman Kessler; Michaela Willi; Ronald Gstir; Anne Krogsdam; Alexandra Lusser; Werner Poewe; Gregor K Wenning; Alexander Hüttenhofer; Nadia Stefanova
Journal:  PLoS One       Date:  2016-03-10       Impact factor: 3.240

7.  MiR-139-5p inhibits the tumorigenesis and progression of oral squamous carcinoma cells by targeting HOXA9.

Authors:  Kai Wang; Jun Jin; Tengxiao Ma; Hongfeng Zhai
Journal:  J Cell Mol Med       Date:  2017-08-05       Impact factor: 5.310

8.  miR-195-5p Suppresses the Proliferation, Migration, and Invasion of Oral Squamous Cell Carcinoma by Targeting TRIM14.

Authors:  Tong Wang; Yipeng Ren; Ruixun Liu; Juntao Ma; Yueyi Shi; Lei Zhang; Rongfa Bu
Journal:  Biomed Res Int       Date:  2017-10-24       Impact factor: 3.411

9.  Expression patterns of microRNA-329 and its clinical performance in diagnosis and prognosis of breast cancer.

Authors:  Pihong Li; Jianda Dong; Xiang Zhou; Weijian Sun; He Huang; Tong Chen; Bing Ye; Zhiqiang Zheng; Mingdong Lu
Journal:  Onco Targets Ther       Date:  2017-11-28       Impact factor: 4.147

10.  MicroRNA-433 inhibits oral squamous cell carcinoma cells by targeting FAK.

Authors:  Yong-Jian Wang; Zi-Feng Zhang; Shao-Hua Fan; Juan Zhuang; Qun Shan; Xin-Rui Han; Xin Wen; Meng-Qiu Li; Bin Hu; Chun-Hui Sun; Bin Qiao; Qian Tao; Dong-Mei Wu; Jun Lu; Yuan-Lin Zheng
Journal:  Oncotarget       Date:  2017-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.